Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis

Hypersensitivity pneumonitis (HP) is an immunologically mediated form of lung disease resulting from inhalational exposure to any of a large variety of antigens. A subgroup of patients with HP develops pulmonary fibrosis (fibrotic HP; FHP), a significant cause of morbidity and mortality. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández Pérez, Evans R., Crooks, James L., Swigris, Jeffrey J., Solomon, Joshua J., Mohning, Michael P., Huie, Tristan J., Koslow, Matthew, Lynch, David A., Groshong, Steve D., Fier, Kaitlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Study Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181708/
https://www.ncbi.nlm.nih.gov/pubmed/34109243
http://dx.doi.org/10.1183/23120541.00054-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181708/
https://www.ncbi.nlm.nih.gov/pubmed/34109243
http://dx.doi.org/10.1183/23120541.00054-2021

Ejemplares similares